Literature DB >> 15631541

Infections associated with medical devices: pathogenesis, management and prophylaxis.

Christof von Eiff1, Bernd Jansen, Wolfgang Kohnen, Karsten Becker.   

Abstract

The insertion or implantation of foreign bodies has become an indispensable part in almost all fields of medicine. However, medical devices are associated with a definitive risk of bacterial and fungal infections. Foreign body-related infections (FBRIs), particularly catheter-related infections, significantly contribute to the increasing problem of nosocomial infections. While a variety of micro-organisms may be involved as pathogens, staphylococci account for the majority of FBRIs. Their ability to adhere to materials and to promote formation of a biofilm is the most important feature of their pathogenicity. This biofilm on the surface of colonised foreign bodies is regarded as the biological correlative for the clinical experience with FBRI, that is, that the host defence mechanisms often seem to be unable to handle the infection and, in particular, to eliminate the micro-organisms from the infected device. Since antibacterial chemotherapy is also frequently not able to cure these infections despite the use of antibacterials with proven in vitro activity, removal of implanted devices is often inevitable and has been standard clinical practice. However, in specific circumstances, such as infections of implanted medical devices with coagulase-negative staphylococci, a trial of salvage of the device may be justified. All FBRIs should be treated with antibacterials to which the pathogens have been shown to be susceptible. In addition to systemic antibacterial therapy, an intraluminal application of antibacterial agents, referred to as the 'antibiotic-lock' technique, should be considered to circumvent the need for removal, especially in patients with implanted long-term catheters. To reduce the incidence of intravascular catheter-related bloodstream infections, specific guidelines comprising both technological and nontechnological strategies for prevention have been established. Quality assurance, continuing education, choice of the catheter insertion site, hand hygiene and aseptic techniques are aspects of particular interest. Furthermore, all steps in the pathogenesis of biofilm formation may represent targets against which prevention strategies may be directed. Alteration of the foreign body material surface may lead to a change in specific and nonspecific interactions with micro-organisms and, thus, to a reduced microbial adherence. Medical devices made out of a material that would be antiadhesive or at least colonisation resistant would be the most suitable candidates to avoid colonisation and subsequent infection. Another concept for the prevention of FBRIs involves the impregnation of devices with various substances such as antibacterials, antiseptics and/or metals. Finally, further studies are needed to translate the knowledge on the mechanisms of biofilm formation into applicable therapeutic and preventive strategies.

Entities:  

Mesh:

Year:  2005        PMID: 15631541     DOI: 10.2165/00003495-200565020-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  262 in total

Review 1.  Catheter-related infections: diagnosis and intravascular treatment.

Authors:  E Bouza; A Burillo; P Muñoz
Journal:  Clin Microbiol Infect       Date:  2002-05       Impact factor: 8.067

2.  Synergism between chlorhexidine and sulphadiazine.

Authors:  L B Quesnel; A R Al-Najjar; P Buddhavudhikrai
Journal:  J Appl Bacteriol       Date:  1978-12

3.  Central venous catheter exchange by guidewire for treatment of catheter-related bacteraemia in patients undergoing BMT or intensive chemotherapy.

Authors:  E Martínez; J Mensa; M Rovira; J A Martínez; A Marcos; M Almela; E Carreras
Journal:  Bone Marrow Transplant       Date:  1999-01       Impact factor: 5.483

Review 4.  Intravascular-catheter-related infections.

Authors:  I Raad
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

5.  Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis.

Authors:  D L Ciresi; R M Albrecht; P A Volkers; D J Scholten
Journal:  Am Surg       Date:  1996-08       Impact factor: 0.688

6.  Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis.

Authors:  Sabine Dobinsky; Kathrin Kiel; Holger Rohde; Katrin Bartscht; Johannes K-M Knobloch; Matthias A Horstkotte; Dietrich Mack
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  Consequences of intravascular catheter sepsis.

Authors:  P M Arnow; E M Quimosing; M Beach
Journal:  Clin Infect Dis       Date:  1993-06       Impact factor: 9.079

8.  Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse.

Authors:  G Romanò; M Berti; B P Goldstein; A Borghi
Journal:  Zentralbl Bakteriol       Date:  1993-08

9.  Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models.

Authors:  Nelly A Kuklin; Gregory D Pancari; Timothy W Tobery; Leslie Cope; Jesse Jackson; Charles Gill; Karen Overbye; Kevin P Francis; Jun Yu; Donna Montgomery; Annaliesa S Anderson; William McClements; Kathrin U Jansen
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Prevention of biofilm formation by polymer modification.

Authors:  B Jansen; W Kohnen
Journal:  J Ind Microbiol       Date:  1995-10
View more
  81 in total

1.  The biofilm-controlling functions of rechargeable antimicrobial N-halamine dental unit waterline tubing.

Authors:  Nuala Porteous; John Schoolfield; Jie Luo; Yuyu Sun
Journal:  J Clin Dent       Date:  2011

2.  Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci.

Authors:  Anne J M Loonen; Arjan R Jansz; Jeandery N B Bergland; Marion Valkenburg; Petra F G Wolffs; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 3.  Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.

Authors:  Jasmin Hum; Aldo R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2012-02-24       Impact factor: 3.896

4.  An extended spectrum bactericidal titanium dioxide (TiO2) coating for metallic implants: in vitro effectiveness against MRSA and mechanical properties.

Authors:  Maximilian Haenle; Andreas Fritsche; Carmen Zietz; Rainer Bader; Frank Heidenau; Wolfram Mittelmeier; Hans Gollwitzer
Journal:  J Mater Sci Mater Med       Date:  2010-12-29       Impact factor: 3.896

5.  Systematic survey of nonspecific agglutination by Candida spp. in latex assays.

Authors:  Karsten Becker; Ahmed S Almasri; Christof von Eiff; Georg Peters; Christine Heilmann; Wolfgang Fegeler
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

6.  Fluorescence-based bacterial overlay method for simultaneous in situ quantification of surface-attached bacteria.

Authors:  Rainer Müller; Gerhard Gröger; Karl-Anton Hiller; Gottfried Schmalz; Stefan Ruhl
Journal:  Appl Environ Microbiol       Date:  2007-02-16       Impact factor: 4.792

7.  Experimental study on the use of a chlorhexidine-loaded carboxymethylcellulose gel as antibacterial coating for hernia repair meshes.

Authors:  B Pérez-Köhler; S Benito-Martínez; M Rodríguez; F García-Moreno; G Pascual; J M Bellón
Journal:  Hernia       Date:  2019-02-26       Impact factor: 4.739

8.  Fast disinfecting antimicrobial surfaces.

Authors:  Ahmad E Madkour; Jeffery M Dabkowski; Klaus Nusslein; Gregory N Tew
Journal:  Langmuir       Date:  2009-01-20       Impact factor: 3.882

9.  Chlorhexidine salt-loaded polyurethane orthodontic chains: in vitro release and antibacterial activity studies.

Authors:  Karine Padois; Valérie Bertholle; Fabrice Pirot; Truc Thanh Ngoc Hyunh; Alessandra Rossi; Paolo Colombo; Françoise Falson; Fabio Sonvico
Journal:  AAPS PharmSciTech       Date:  2012-10-23       Impact factor: 3.246

Review 10.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.